Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial
Behazine Combadière, Annika Vogt, Brice Mahé et al. · 2010
Read Preferential Amplification of CD8 Effector-T Cells after Transcutaneous Application of an Inactivated Influenza Vaccine: A Randomized Phase I Trial by Behazine Combadière, Annika Vogt, Brice Mahé et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010818.txt.
Description
Behazine Combadière and colleagues ran an early human trial of a needle-free flu vaccine, in PLOS ONE in 2010. Standard flu shots train antibodies well but raise weak killer T cell responses. Killer CD8 cells matter most against new flu strains that antibodies miss. The skin is rich in immune sentinels, and hair follicles offer a route in.
Volunteers received inactivated flu vaccine through the skin in a randomized phase I trial. The skin route preferentially amplified CD8 effector T cells. That bias is exactly what flu vaccinology has been missing. A safe, needle-free patch that trains killer cells could change both yearly flu shots and pandemic response.
Catalog record
| CREATOR | Behazine Combadière, Annika Vogt, Brice Mahé et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010818